Results 201 to 210 of about 2,071,373 (281)

Circadian metabolic dysfunction in MASLD: Physiological insights and future directions

Journal of Diabetes Investigation, Volume 17, Issue 11, Page 1867-1869, November 2026.
You‐Cheol Hwang
wiley   +1 more source

Enhancing Thrombolysis Safety in Post-Acute Ischemic Stroke with Tissue Plasminogen Activator-Associated Microparticles. [PDF]

ACS Nano
Spanò R, Portioli C, Geroski T, Felici A, Palange AL, Gawne PJ, Mamberti S, Avancini G, Palomba R, Bonnard T, Moore TL, Del Sette M, Filipovic N, Vivien D, Decuzzi P.   +14 more
europepmc   +1 more source

Poor long-term fellow-eye outcomes after vitrectomy with subretinal tissue plasminogen activator for AMD-related submacular hemorrhage. [PDF]

Graefes Arch Clin Exp Ophthalmol
Fried S, Vorobichik Berar O, David D, Arazi M, Klain B, Cohen GY, Fogel Levin M, Platner E, Katz G, Hostovsky A.   +9 more
europepmc   +1 more source

Predictive value of serum homocysteine and potassium ion for short-term prognosis of patients with acute cerebral infarction following intravenous thrombolysis with recombinant tissue plasminogen activator. [PDF]

Thromb J
Pang L, Sun Y, He M, Xu B.
europepmc   +1 more source

Outcomes of Emergent Stenting with Antiplatelet Therapy in Patients with Large Vessel Occlusion Stroke with or without Intravenous Tissue Plasminogen Activator. [PDF]

J Neuroendovasc Ther
Teranishi K, Fujiwara S, Sunohara T, Koyanagi M, Goto M, Takeda J, Fukumitsu R, Fukui N, Takano Y, Nakajima K, Naramoto Y, Yamamoto Y, Nishii R, Kawade S, Takamatsu T, Tokuda M, Tomita H, Yoshimoto M, Ohara N, Sakai N, Ohta T.   +20 more
europepmc   +1 more source

Intravitreal tissue plasminogen activator in submacular haemorrhage

Indian Journal of Ophthalmology, 1999
Singh Preetam, Singh Ravijit, Kishore K, Vig Vipin, Singh Rajbir, Singh Balbir   +5 more
doaj  

Transcranial Doppler ultrasound evaluation of vascular recanalization following tissue plasminogen activator intravenous thrombolysis in acute middle cerebral artery occlusion: A case report and literature review. [PDF]

SAGE Open Med Case Rep
Lv S, Liu R, Sun J, Liu H, Bian J, Ding C, Guo X.   +6 more
europepmc   +1 more source

A pilot randomised, open label controlled trial comparing safety and efficacy of pleural irrigation with normal saline versus intrapleural tissue plasminogen activator and DNase (fibrinolytic therapy) in pleural infection. [PDF]

BMC Pulm Med
Rozi SNM, Jailaini MFM, Azmel AA, Ismail NAN, Fuad NFN, Zainal IA, Ghan SL, Shah SA, Rahim MJC, Hamid MFA.   +9 more
europepmc   +1 more source

Recurrence associated with 2-year visual acuity after subretinal tissue plasminogen activator for submacular hemorrhage in neovascular age-related macular degeneration. [PDF]

Jpn J Ophthalmol
Tanaka M, Miyata M, Hata M, Ooto S, Tamura H, Kido A, Ueda-Arakawa N, Miyake M, Takahashi A, Muraoka Y, Tsujikawa A.   +10 more
europepmc   +1 more source

Asparagine Endopeptidase Inhibition Attenuates Tissue Plasminogen Activator-Induced Brain Hemorrhagic Transformation After Ischemic Stroke. [PDF]

CNS Neurosci Ther
Xie G, Jiang G, Huang L, Sun S, Li X, Wu B, Wang H, Zhang Z, Ye K, Yu Y, Xiong J.   +10 more
europepmc   +1 more source